NYSE Euronext (NYX) today announced trading volumes for its global cash
equities and derivatives exchanges for
Highlights
-
NYSE , NYSE Arca and NYSE Amex (“NYSE Group”) U.S. cash products handled ADV inAugust 2009 increased 6.4% and 3.9% compared toAugust 2008 andJuly 2009 , respectively, and increased 11.3% year-to-date.NYSE Group matched share of all U.S. equity trading volume inAugust 2009 was 27.3%, compared to matched market share of 21.1% for our next largest competitor. -
NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Year-to-date, total Tape A and Tape B consolidated ADV increased a combined 43.2%, compared to the prior year period, while Tape C consolidated ADV has increased only 2.3% during the same period. -
NYSE Euronext European cash products ADV of 1.3 million transactions
in
August 2009 increased 5.3% and 10.1% compared toAugust 2008 andJuly 2009 , respectively. Year-to-date transactions of 1.4 million were 7.8% below the same period last year. -
NYSE Euronext European derivatives products ADV in
August 2009 was 3.5 million contracts, up 15.9% fromAugust 2008 , and down 1.7% fromJuly 2009 . Total interest rate products ADV was 1.9 million contracts, up 12.0% compared toAugust 2008 and total equity products ADV of 1.6 million contracts increased 21.8% from 1.3 million contracts. -
NYSE Euronext U.S. equity options ADV of 2.3 million contracts in
August 2009 increased 66.9% compared toAugust 2008 levels, but decreased 5.5% fromJuly 2009 . The increase in ADV year-over-year was driven mostly by the addition of the former Amex options business.
1 Euronext equities transactions count each buy and sell
order as separate transactions,
Cash Trading
U.S. Cash
NYSE Group U.S. cash products handled ADV in
-
Total Tape A consolidated ADV in
August 2009 increased 35.7% to 5.9 billion shares compared to 4.3 billion shares inAugust 2008 and increased 15.9% compared toJuly 2009 . Year-to-date, total Tape A consolidated ADV of 6.0 billion shares was 32.9% above the prior year period. -
Tape A matched ADV of
NYSE Group inAugust 2009 increased 9.3% to 2.0 billion shares compared toAugust 2008 and 6.8% compared toJuly 2009 . Year-to-date,NYSE Group matched ADV in Tape A increased 9.5% compared to the prior year period. -
NYSE Group’s Tape A matched market share in
August 2009 was 33.8%, down from 36.6% inJuly 2009 , and compared to matched market share of 16.5% for our next largest competitor. The decline in market share inAugust 2009 was driven in part by a significant increase in TRF executed volume in the top-10 most actively traded stocks which represented approximately 39% of Tape A consolidated activity, up from approximately 26% inJuly 2009 . Excluding the impact of the volume of the top-10 most actively traded stocks, Tape A matched market share would have been 39.4% in July and 39.1% in August. Largely as a result of the activity in these top-10 stocks, TRF market share across Tape A increased 370 basis points inAugust 2009 to 37.6% and up from 25.0% inDecember 2008 . -
Designated Market Maker (“DMM”) participation in
August 2009 was 8.8%, compared to 8.7% inJuly 2009 . Supplemental Liquidity Provider (“SLP”) participation inAugust 2009 was 7.6%, compared to 7.7% inJuly 2009 . DMM and SLP participation pertain only to trading onNYSE .
NYSE Arca and NYSE Amex-listed (Tape B)
-
Total Tape B consolidated ADV in
August 2009 increased 25.1% to 1.5 billion shares compared toAugust 2008 and decreased 3.8% compared toJuly 2009 . Year-to-date, total Tape B consolidated ADV of 2.1 billion shares was 81.5% above the prior year period. -
NYSE Group’s matched ADV of Tape B in
August 2009 increased 11.5% to 349 million shares compared toAugust 2008 and declined 2.8% compared toJuly 2009 . Year-to-date, NYSE Group Tape B matched ADV was 55.3% above the prior year period. -
Tape B matched market share of
NYSE Group inJuly 2009 was 23.3%, up from 23.1% inJuly 2009 , compared to matched market share of 24.2% for our next largest competitor. TRF market share across Tape B increased inAugust 2009 to 34.8% from 21.5% inDecember 2008 .
Nasdaq-listed (Tape C)
-
Total Tape C consolidated ADV in
August 2009 increased 13.5% to 2.2 billion shares, compared to 1.9 billion shares inAugust 2008 . Tape C consolidated volumes represented approximately 23% of all Consolidated Tape trading in the U.S. inAugust 2009 . Year-to-date, total Tape C consolidated ADV was 2.3% above the prior year period. -
NYSE Group’s matched ADV of Tape C decreased 14.7% to 271 million
shares in
August 2009 compared to 318 million shares inAugust 2008 and decreased 4.9% compared toJuly 2009 . Year-to-date, NYSE Group’s Tape C matched ADV decreased 13.6% to 321 million shares. -
NYSE Group’s Tape C matched market share decreased to 12.6% from 12.9%
in
August 2009 , compared to matched market share of 31.8% for our nearest competitor, down from 33.1% in July. TRF market share across Tape C increased inAugust 2009 to 40.2% from 29.9% inDecember 2008 .
Exchange Traded Products
-
NYSE Group matched exchange-traded products ADV (included in volumes from Tape B and Tape C noted above) was flat inAugust 2009 compared to the prior year period at 332 million shares. Year-to-date, matched exchange-traded products ADV was 44.1% above the prior year period.
European Cash
NYSE Euronext European cash products ADV of 1.3 million transactions in
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in
-
Total interest rate products ADV increased 12.0% to 1.9 million
contracts from 1.7 million contracts in
August 2008 and increased 17.9% fromJuly 2009 . Year-to-date, total interest rate products ADV decreased 14.4% compared to the prior year period. -
Total equity products (including Bclear) ADV increased 21.8% to 1.6
million contracts from
August 2008 and decreased 17.7% compared toJuly 2009 . Total equity products ADV in August executed through our full-service LIFFE CONNECT trading platform was 0.9 million contracts, in-line with the prior year period. Year-to-date total equity products ADV increased 16.6% above the prior year period.
U.S. Derivatives
NYSE Euronext’s U.S. equity options (NYSE Arca and NYSE Amex) ADV in
Please click here for the Monthly Transaction Activity Data Table.
About
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include,
but are not limited to, statements concerning NYSE Euronext’s plans,
objectives, expectations and intentions and other statements that are
not historical or current facts. Forward-looking statements are based on
NYSE Euronext’s current expectations and involve risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied in such forward-looking statements. Factors that
could cause NYSE Euronext’s results to differ materially from current
expectations include, but are not limited to: NYSE Euronext’s ability to
implement its strategic initiatives, economic, political and market
conditions and fluctuations, government and industry regulation,
interest rate risk and U.S. and global competition, and other factors
detailed in NYSE Euronext’s reference document for 2008 ("document de
référence") filed with the French Autorité des Marchés Financiers
(Registered on
NYSE Euronext |
|||||||||||||||||||||||
Monthly Volume Summary - Cash Products |
|||||||||||||||||||||||
Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | ||||||||||||||||||||
(Unaudited) | Aug-09 | Aug-08 | % Chg | Aug-09 | Aug-08 | % Chg | YTD 2009 |
% Chg vs. YTD 2008 |
YTD 2009 |
% Chg vs. YTD 2008 |
|||||||||||||
Number of Trading Days - European Markets | 21 | 21 | 21 | 21 | 169 | 169 | |||||||||||||||||
Number of Trading Days - U.S. Markets | 21 | 21 | 21 | 21 | 167 | 167 | |||||||||||||||||
European Cash Products (trades in thousands) | 1,303 | 1,238 | 5.3% | 27,364 | 25,990 | 5.3% | 1,369 | -7.8% | 231,415 | -8.4% | |||||||||||||
Equities | 1,252 | 1,198 | 4.5% | 26,283 | 25,148 | 4.5% | 1,310 | -8.7% | 221,395 | -9.2% | |||||||||||||
Exchange-Traded Funds | 14 | 5 | 162.9% | 290 | 110 | 162.9% | 14 | 89.9% | 2,385 | 88.7% | |||||||||||||
Structured Products | 32 | 31 | 3.9% | 679 | 654 | 3.9% | 40 | 3.9% | 6,697 | 3.2% | |||||||||||||
Bonds | 5 | 4 | 44.6% | 112 | 77 | 44.6% | 6 | 5.9% | 938 | 5.3% | |||||||||||||
U.S. Cash Products (shares in millions) 2 | 2,937 | 2,760 | 6.4% | 61,679 | 57,965 | 6.4% | 3,586 | 11.3% | 598,838 | 10.7% | |||||||||||||
NYSE Listed (Tape A) Issues 1 | |||||||||||||||||||||||
NYSE Group Handled Volume 2 |
2,199 | 2,021 | 8.8% | 46,176 | 42,443 | 8.8% | 2,609 | 8.9% | 435,677 | 8.2% | |||||||||||||
NYSE Group Matched Volume 3 | 1,989 | 1,819 | 9.3% | 41,779 | 38,208 | 9.3% | 2,365 | 9.5% | 394,987 | 8.8% | |||||||||||||
Total NYSE Listed Consolidated Volume | 5,890 | 4,342 | 35.7% | 123,696 | 91,180 | 35.7% | 6,035 | 32.9% | 1,007,811 | 32.2% | |||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 37.3% | 46.5% | -9.2% | 37.3% | 46.5% | -9.2% | 43.2% | -9.6% | 43.2% | -9.6% | |||||||||||||
Matched Volume 3 | 33.8% | 41.9% | -8.1% | 33.8% | 41.9% | -8.1% | 39.2% | -8.4% | 39.2% | -8.4% | |||||||||||||
NYSE Arca & Amex (Tape B) Listed Issues | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 403 | 362 | 11.4% | 8,459 | 7,595 | 11.4% | 585 | 54.0% | 97,648 | 53.1% | |||||||||||||
NYSE Group Matched Volume 3 | 349 | 313 | 11.5% | 7,326 | 6,570 | 11.5% | 512 | 55.3% | 85,476 | 54.4% | |||||||||||||
Total NYSE Arca & Amex Listed Consolidated Volume | 1,497 | 1,196 | 25.1% | 31,441 | 25,126 | 25.1% | 2,106 | 81.5% | 351,727 | 80.4% | |||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 26.9% | 30.2% | -3.3% | 26.9% | 30.2% | -3.3% | 27.8% | -4.9% | 27.8% | -4.9% | |||||||||||||
Matched Volume 3 | 23.3% | 26.1% | -2.8% | 23.3% | 26.1% | -2.8% | 24.3% | -4.1% | 24.3% | -4.1% | |||||||||||||
Nasdaq Listed (Tape C) Issues | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 335 | 377 | -11.1% | 7,044 | 7,926 | -11.1% | 392 | -11.9% | 65,513 | -12.5% | |||||||||||||
NYSE Group Matched Volume 3 | 271 | 318 | -14.7% | 5,695 | 6,674 | -14.7% | 321 | -13.6% | 53,641 | -14.1% | |||||||||||||
Total Nasdaq Listed Consolidated Volume | 2,150 | 1,893 | 13.5% | 45,144 | 39,758 | 13.5% | 2,285 | 2.3% | 381,518 | 1.7% | |||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 15.6% | 19.9% | -4.3% | 15.6% | 19.9% | -4.3% | 17.2% | -2.8% | 17.2% | -2.8% | |||||||||||||
Matched Volume 3 | 12.6% | 16.8% | -4.2% | 12.6% | 16.8% | -4.2% | 14.1% | -2.6% | 14.1% | -2.6% | |||||||||||||
Exchange-Traded Funds 1,4 | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 381 | 381 | -0.1% | 8,002 | 8,006 | -0.1% | 580 | 43.5% | 96,858 | 42.7% | |||||||||||||
NYSE Group Matched Volume 3 | 332 | 332 | 0.0% | 6,974 | 6,973 | 0.0% | 509 | 44.1% | 84,965 | 43.2% | |||||||||||||
Total ETF Consolidated Volume | 1,469 | 1,245 | 18.0% | 30,855 | 26,141 | 18.0% | 2,145 | 76.2% | 358,169 | 75.1% | |||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 25.9% | 30.6% | -4.7% | 25.9% | 30.6% | -4.7% | 27.0% | -6.2% | 27.0% | -6.2% | |||||||||||||
Matched Volume 3 | 22.6% | 26.7% | -4.1% | 22.6% | 26.7% | -4.1% | 23.7% | -5.3% | 23.7% | -5.3% |
NYSE Euronext |
|||||||||||||||||||||||
Monthly Volume Summary - Derivatives Products |
|||||||||||||||||||||||
Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | ||||||||||||||||||||
(Unaudited; contracts in thousands) | Aug-09 | Aug-08 | % Chg | Aug-09 | Aug-08 | % Chg | YTD 2009 |
% Chg vs. YTD 2008 |
YTD 2009 |
% Chg vs. YTD 2008 |
|||||||||||||
Number of Trading Days - European Markets | 21 | 21 | 21 | 21 | 169 | 169 | |||||||||||||||||
Number of Trading Days - U.S. Markets | 21 | 21 | 21 | 21 | 167 | 167 | |||||||||||||||||
European Derivatives Products | 3,501 | 3,022 | 15.9% | 73,525 | 63,453 | 15.9% | 4,120 | -1.1% | 696,292 | -1.7% | |||||||||||||
of which Bclear | 643 | 412 | 56.3% | 13,513 | 8,647 | 56.3% | 1,101 | 51.7% | 186,033 | 50.8% | |||||||||||||
Total Interest Rate Products | 1,868 | 1,668 | 12.0% | 39,233 | 35,030 | 12.0% | 1,982 | -14.4% | 334,914 | -14.9% | |||||||||||||
Short Term Interest Rate Products | 1,758 | 1,547 | 13.6% | 36,923 | 32,491 | 13.6% | 1,883 | -14.8% | 318,206 | -15.3% | |||||||||||||
Medium and Long Term Interest Rate Products 5 | 110 | 121 | -9.0% | 2,310 | 2,539 | -9.0% | 99 | -6.6% | 16,709 | -7.1% | |||||||||||||
Total Credit Derivatives Products (Bclear) | - | - | - | - | - | - | |||||||||||||||||
Total Equity Products 6 | 1,590 | 1,305 | 21.8% | 33,389 | 27,413 | 21.8% | 2,092 | 16.6% | 353,535 | 15.9% | |||||||||||||
Individual Equity Products | 1,041 | 794 | 31.1% | 21,868 | 16,679 | 31.1% | 1,482 | 26.6% | 250,430 | 25.9% | |||||||||||||
Equity Index Products | 549 | 511 | 7.3% | 11,521 | 10,734 | 7.3% | 610 | -2.2% | 103,105 | -2.8% | |||||||||||||
of which Bclear | 643 | 412 | 56.3% | 13,513 | 8,647 | 56.3% | 1,101 | 51.7% | 186,033 | 50.8% | |||||||||||||
Individual Equity Products | 534 | 308 | 73.2% | 11,214 | 6,474 | 73.2% | 972 | 55.9% | 164,269 | 55.0% | |||||||||||||
Equity Index Products | 109 | 103 | 5.8% | 2,299 | 2,173 | 5.8% | 129 | 26.4% | 21,765 | 25.7% | |||||||||||||
Commodity Products | 43 | 48 | -10.7% | 902 | 1,011 | -10.7% | 46 | -15.3% | 7,842 | -15.8% | |||||||||||||
of which Bclear | - | - | - | - | - | - | |||||||||||||||||
U.S. Derivatives Products | |||||||||||||||||||||||
U.S. Derivatives Products - Equity Options 7 | |||||||||||||||||||||||
NYSE Group Options Contracts | 2,307 | 1,382 | 66.9% | 48,448 | 29,026 | 66.9% | 2,422 | 42.2% | 404,461 | 41.3% | |||||||||||||
Total Consolidated Options Contracts | 12,710 | 11,504 | 10.5% | 266,913 | 241,579 | 10.5% | 13,471 | 3.8% | 2,249,685 | 3.2% | |||||||||||||
NYSE Group Share of Total | 18.2% | 12.0% | 18.2% | 12.0% | 18.0% | 4.9% | 18.0% | 4.9% | |||||||||||||||
NYSE Liffe U.S. | |||||||||||||||||||||||
Precious Metals Futures Volume | 12.2 | - | 255.4 | - | 16.0 | - | 2,674.9 | - |
1 | Includes all volume executed in NYSE Group crossing sessions. | |
2 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
3 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
4 | Data included in previously identified categories. | |
5 | Data includes currency products. | |
6 |
Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives. | |
7 | Includes trading in U.S. equity options contracts, not equity-index options. | |
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. | ||
US Equities data has been updated for Amex integration for October 2008 forward. |